Diabetes Treatment: EDTA Chelation

Ethylene diamine tetracidic acid (EDTA) chelation is an FDA-approved intravenous therapy that removes toxic heavy metals from the blood, improves circulation, and restores arterial health. Chelation is often used to treat patients with early kidney disease because, even at low levels, lead has been shown to speed up the progression of kidney damage.  

It is important to note, however, that intravenous therapy is never offered to patients with severe kidney failure because their bodies cannot handle that much excess fluid.

Because it helps improve blood flow and promotes arterial health, EDTA chelation is also effective for treating diabetes. It is just one of the many alternative treatments for diabetes that is studied and used regularly at the Whitaker Wellness Institute.